|Author(s)/Faculty: Alain Algazi, MD; Robert H. I. Andtbacka, MD, CM, FACS, FRCSC|
|Release Date: 9/18/2015||Expiration Date: 9/23/2016|
|Credit Type: CME||Number of Credits: 0|
|Content Type: Article||Provider: |
|This CME Activity evaluates the clinical safety and efficacy profiles of new and emerging therapies for the treatment of melanoma, including immunotherapy, targeted therapy, and intralesional therapy.